Avascular Necrosis
131
6
34
47
Key Insights
Highlights
Success Rate
56% trial completion
Published Results
26 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
28.2%
37 terminated out of 131 trials
56.0%
-30.6% vs benchmark
18%
24 trials in Phase 3/4
55%
26 of 47 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 47 completed trials
Clinical Trials (131)
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Cemented vs Cementless Persona Keel RCT
Persona Partial Knee Clinical Outcomes Study
Comprehensive Nano - Post Market Clinical Follow-Up Study
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
Anatomical Shoulder Domelock System Study
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Perform Humeral System Study
Pyrocarbon Clinical Follow-up Study
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
Allofit® IT With HXPE in Total Hip Arthroplasty
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
BC Study of G7 Cup and Compatible Femoral Stems
Database Retrieval for the Comprehensive Shoulder
Persona Ti-Nidium Post-Market Clinical Follow-up